Want to join the conversation?
$BIIB 2Q15 Q&A: Roden of UBS asked a question about the Alzheimer’s program. George said that BIIB has analysed the data carefully. BIIB is trying to push the dose as high and hard to remove as much amyloid as possible. All this is factored into sample size. BIIB has designed a study that takes into account increases dose and duration work better.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.